Suppr超能文献

微导管选择性注射技术联合超低剂量造影剂在既往有急性肾损伤患者经皮冠状动脉介入治疗中的应用:一例报告

Microcatheter selective injection technique using ultra low contrast for percutaneous coronary intervention in patients with previous acute kidney injury: a case report.

作者信息

Mangkuanom Arwin Saleh, Satrio Revan, Mendel Brian, Firman Doni, Iryuza Nanda, Alkatiri Amir Aziz

机构信息

Invasive Diagnostic and Non Surgical Intervention Division, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

出版信息

Front Cardiovasc Med. 2025 Jul 10;12:1607466. doi: 10.3389/fcvm.2025.1607466. eCollection 2025.

Abstract

BACKGROUND

Contrast-induced nephropathy (CIN) is a risk in angiographic procedures, especially for patients with acute kidney injury (AKI). To mitigate this risk, ultra-low contrast percutaneous coronary intervention (ULC-PCI) has been developed, which minimizes the use of contrast agents.

CASE SUMMARY

A 54-year-old woman with a history of AKI from a prior percutaneous coronary intervention (PCI) was found to have coronary artery disease with three vessels disease and chronic total occlusion in the right coronary artery. To minimize contrast use, she underwent ultra-low contrast PCI using the "microcatheter injection" technique, with only 5 cc of contrast used during the procedure. At one-year follow-up, the patient's LVEF improved from 33% to 56%, symptoms resolved with no chest pain. Her estimated glomerular filtration rate (eGFR) showed no significant decrease, since serum creatinine increased slightly from 1.59 mg/dl to 1.61 mg/dl. and eGFR decreased from 39 to 38 ml/min/1.73 m in 72 h.

CONCLUSIONS

The microcatheter injection technique may serve as a viable strategy for percutaneous coronary intervention (PCI) in patients with eGFR < 30 ml/min/1.73 m or history of contrast-induced nephropathy.

摘要

背景

造影剂肾病(CIN)是血管造影术的一种风险,尤其是对于急性肾损伤(AKI)患者。为降低这种风险,已开发出超低造影剂经皮冠状动脉介入治疗(ULC-PCI),其可将造影剂的使用降至最低。

病例摘要

一名54岁女性,既往经皮冠状动脉介入治疗(PCI)后有急性肾损伤病史,被发现患有冠状动脉疾病,三支血管病变,右冠状动脉慢性完全闭塞。为尽量减少造影剂使用,她采用“微导管注射”技术接受了超低造影剂PCI,手术过程中仅使用了5毫升造影剂。在一年的随访中,患者的左心室射血分数(LVEF)从33%提高到56%,症状缓解,无胸痛。她的估计肾小球滤过率(eGFR)没有显著下降,因为血清肌酐从1.59 mg/dl略有升至1.61 mg/dl,且eGFR在72小时内从39降至38 ml/min/1.73 m²。

结论

对于估计肾小球滤过率(eGFR)<30 ml/min/1.73 m²或有造影剂肾病病史的患者,微导管注射技术可能是经皮冠状动脉介入治疗(PCI)的一种可行策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c79/12286955/79f8e72e49a0/fcvm-12-1607466-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验